Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy.

Agrawal, Lokesh; Engel, Kelly B; Greytak, Sarah R; Moore, Helen M

Agrawal, Lokesh; Engel, Kelly B; Greytak, Sarah R; Moore, Helen M.

Afiliação

Agrawal L; Biorepositories and Biospecimen Research Branch (BBRB), Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 9609 Medical Center Drive, Bethesda, Maryland, USA.
Engel KB; Preferred Solutions Group, Washington D.C., USA.
Greytak SR; Kelly Government Solutions, Rockville, Maryland, USA.
Moore HM; Biorepositories and Biospecimen Research Branch (BBRB), Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 9609 Medical Center Drive, Bethesda, Maryland, USA. Electronic address: moorehe@mail.nih.gov.

Semin Cancer Biol ; 52(Pt 2): 26-38, 2018 10.

Article em En | MEDLINE | ID: mdl-29258857

Assuntos

Biomarcadores Tumorais/imunologia; Neoplasias/imunologia; Animais; Humanos; Imunoterapia/métodos; Oncologia/métodos

Palavras-chave

Biomarker; Biospecimen science; Cancer immunotherapy; Preanalytical variability

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google